Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Neutral

Exponential Moving Average

Buy

Relative Strength Index

Strong Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Buy

A

Spire Inc. (SR)

Natural Gas Distribution

https://www.spireenergy.com

Spire Inc is a public utility holding company with three reportable business segments: Gas Utility , Gas Marketing and Midstream. The Gas Utility segment includes the regulated operations of Laclede Gas, Alabama Gas Corporation (Alagasco), and EnergySouth Inc. The Utilities businesses operations include the purchase, retail, distribution, and sale of natural gas in Missouri, Alabama, and Mississippi. The Gas Utility segment generates a majority of the company's revenue but is subject to seasonal fluctuations. The Gas Marketing segment includes Laclede Energy Resources, Inc, whose operations include the marketing of natural gas and related activities on a non-regulated basis and the Midstream segment includes transportation and storage of natural gas.

700 MARKET STREET
ST LOUIS, MO

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/03/1950

Market Cap

3,740,499,885

Shares Outstanding

53,230,000

Weighted SO

53,229,195

Total Employees

N/A

Upcoming Earnings

N/A

Beta

0.5250

Last Div

3.0200

Range

53.77-68.02

Chg

0.5200

Avg Vol

356291

Mkt Cap

3740499885

Exch

NYSE

Country

US

Phone

314 342 0500

DCF Diff

1.2232

DCF

72.5332

Div Yield

0.0461

P/S

1.4334

EV Multiple

10.7402

P/FV

1.1212

Div Yield %

4.6086

P/E

15.2105

PEG

1.7314

Payout

0.7216

Current Ratio

0.4830

Quick Ratio

0.3484

Cash Ratio

0.0043

DSO

48.3105

DIO

48.5892

Op Cycle

96.8997

DPO

43.3312

CCC

53.5685

Gross Margin

0.3376

Op Margin

0.1780

Pretax Margin

0.1135

Net Margin

0.0942

Eff Tax Rate

0.1702

ROA

0.0229

ROE

0.0774

ROCE

0.0516

NI/EBT

0.8298

EBT/EBIT

0.6373

EBIT/Rev

0.1780

Debt Ratio

0.4202

D/E

1.3501

LT Debt/Cap

0.5066

Total Debt/Cap

0.5745

Int Coverage

2.3253

CF/Debt

0.1923

Equity Multi

3.2134

Rec Turnover

7.5553

Pay Turnover

8.4235

Inv Turnover

7.5120

FA Turnover

0.3717

Asset Turnover

0.2436

OCF/Share

15.0017

FCF/Share

0.9515

Cash/Share

17.9792

OCF/Sales

0.3317

FCF/OCF

0.0634

CF Coverage

0.1923

ST Coverage

0.8030

CapEx Coverage

1.0677

Div&CapEx Cov

0.8761

P/BV

1.1212

P/B

1.1212

P/S

1.4334

P/E

15.2105

P/FCF

68.1330

P/OCF

4.3175

P/CF

4.3175

PEG

1.7314

P/S

1.4334

EV Multiple

10.7402

P/FV

1.1212

DPS

2.9850

Latest Headlines (EST)

Benzinga Jul 17, 05:43 Hansa Biopharma Reports Second Quarter and Interim January-June 2025 Financial Results GlobeNewswire Inc. Jul 16, 23:53 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hims & Hers and Sarepta and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jul 12, 19:37 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hims & Hers, Sarepta, and Petco and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jul 11, 00:40 ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SRPT GlobeNewswire Inc. Jul 05, 15:40 INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Sarepta Therapeutics, Inc. (SRPT) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit The Motley Fool Jul 05, 15:10 2 Unstoppable Growth Stocks to Hold for the Next 20 Years GlobeNewswire Inc. Jul 03, 23:33 Sarepta Therapeutics, Inc. Class Action Notice: Robbins LLP Reminds SRPT Stockholders of the Lead Plaintiff Deadline in the SRPT Class Action Lawsuit GlobeNewswire Inc. Jun 29, 20:00 SRPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit The Motley Fool Jun 28, 20:05 IEFA Is a Great Choice for Most, but I Like VEA ETF Better GlobeNewswire Inc. Jun 28, 14:00 INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT GlobeNewswire Inc. Jun 26, 21:45 DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sarepta Therapeutics GlobeNewswire Inc. Jun 26, 21:38 Sarepta Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. August 25, 2025 Deadline to file Lead Plaintiff Motion. Benzinga Jun 26, 21:25 SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm GlobeNewswire Inc. Jun 15, 19:51 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, ATAI, ICAD on Behalf of Shareholders GlobeNewswire Inc. Jun 15, 18:29 HAPPY FATHER’S DAY and $HARHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger: SVT, SSBK, LNSR, iCAD Benzinga Jun 14, 16:45 Intel Clues Hidden in Pizza Orders? Pentagon Orders Surged Just Before Israel Hit Iran GlobeNewswire Inc. May 18, 22:46 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DNB, LNSR, TASK on Behalf of Shareholders Benzinga May 16, 22:30 $TOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The Merger - DNB, BRDG, LNSR, SSBK GlobeNewswire Inc. May 13, 01:00 Trackinsight Releases 2025 Global ETF Survey: ETF Industry on Overdrive: Shifting Gears, Breaking New Barriers Benzinga Apr 30, 21:25 STEM Mentorship Event Brings Together LA Dodgers Foundation and SoCalGas to Inspire the Next Generation of STEM Professionals

Revenue Product Segmentation